CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -12.5% | 4,000 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 4,000 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -38.9% | 4,000 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -21.7% | 4,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $23,000 | -17.9% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $28,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |